A huge exit on Israeli biomed: Gilead buys Kite Pharma for $11.9 billion in Cash

  Gilead Sciences agreed on Monday to buy Kite Pharma for $11.9 billion in an all-cash deal. This acquisition is one of the biggest ever of a company whose products have not yet approved for marketing. Gilead More...

George Soros reduces Teva stake

– The Soros fund’s portfolio also includes Israeli companies BioBlast Pharma, ClickSoftware Technologies, Kite Pharma, and Mazor Robotics. – Soros Fund Management, George Soros’s More...

Kite Pharma Says Cancer Drug KTE-C19 Showing Great Promise

Eight patients with aggressive non-Hodgkin’s lymphoma treated with Kite Pharma Inc.‘s cancer drug were in complete remission and four others in partial remission, the company announced Monday. Company More...